Sebia USA is a specialized In Vitro Diagnostic player and the world’s leading provider of clinical protein electrophoresis equipment and reagents for screening and monitoring various diseases, primarily in Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy, and rare pathologies. They focus on translating patients' body conditions into a readable language through their 'new language of life' mission, aiming to understand, diagnose, and treat chronic and metabolic diseases. Sebia's core services include Capillary Electrophoresis (CE) technology, which is crucial for unlocking complex conditions related to cancer, obesity, aging, and depression by analyzing protein modifications. Headquartered in France, Sebia sets high standards in CE technology, scientific excellence, and manufacturing capabilities to provide diagnostic solutions worldwide.